Bayesian Capital Management, LP Integra Lifesciences Holdings Corp Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$34.21 - $44.59 $434,467 - $566,293
12,700 New
12,700 $553,000
Q4 2022

Feb 14, 2023
BUY
$42.17 - $58.6 $1.34 Million - $1.86 Million
31,758 New
31,758 $1.78 Million
Q2 2022

Aug 15, 2022
BUY
$53.86 - $66.52 $245,978 - $303,796
4,567 New
4,567 $247,000
Q2 2021

Aug 13, 2021
SELL
$66.79 - $76.63 $197,297 - $226,365
-2,954 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$62.63 - $71.15 $185,009 - $210,177
2,954 New
2,954 $204,000

Others Institutions Holding IART

# of Institutions
241
Shares Held
75.3M
Call Options Held
585K
Put Options Held
21.3K
View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

IART Quotes by TradingView
  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email